U.S., July 10 -- ClinicalTrials.gov registry received information related to the study (NCT07692594) titled 'Heart and Blood Vessels Health in People With Cystic Fibrosis' on July 02.
Brief Summary: Cystic fibrosis (CF) is a disease that affects over 11,000 people in the UK. It is a genetic condition that affects many organs including the lungs, pancreas, kidneys and liver. New drugs called "modulators" have meant people with CF are now living much longer. Until recently, heart disease was rare in CF, but with the new modulators there are increasing concerns that heart disease may become a big problem in the future. This is partly to do with the drugs causing weight gain and higher blood pressure, which are risk factors for heart disease....